These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30554835)
1. [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: A case report]. Chauveau B; Le Loarer F; Bacci J; Baylac F; Dubus P; Ling C; Parrens M Ann Pathol; 2019 Feb; 39(1):29-35. PubMed ID: 30554835 [TBL] [Abstract][Full Text] [Related]
2. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease. Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658 [TBL] [Abstract][Full Text] [Related]
3. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report. Li P; Liu H; Li H; Li A; Yu G; Yin W Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137 [TBL] [Abstract][Full Text] [Related]
4. Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy. Qian YW; Weissmann D; Goodell L; August D; Strair R Leuk Lymphoma; 2009 Feb; 50(2):306-8. PubMed ID: 19197736 [No Abstract] [Full Text] [Related]
5. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease. Karki NR; Arfa AS; Savage N; Kutlar A Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric features of incidental indolent T lymphoblastic proliferations. Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375 [TBL] [Abstract][Full Text] [Related]
7. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature. Chen J; Feng J; Xiao H; Ma Q; Chen Z Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967 [TBL] [Abstract][Full Text] [Related]
8. Indolent T-lymphoblastic proliferation: a name with specific meaning. Ohgami RS; Natkunam Y; Warnke RA Hum Pathol; 2015 Nov; 46(11):1785-6. PubMed ID: 26363525 [No Abstract] [Full Text] [Related]
9. Indolent T-lymphoblastic proliferation: a name with specific meaning--reply. Nathwani BN; Kansal R; Yiakoumis X; Pangalis GA Hum Pathol; 2015 Nov; 46(11):1786-7. PubMed ID: 26410056 [No Abstract] [Full Text] [Related]
10. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review. Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359 [TBL] [Abstract][Full Text] [Related]
11. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow. Wang X; Ng CS; Chen C; Yu G; Yin W Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536 [TBL] [Abstract][Full Text] [Related]
12. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome. Walters M; Pittelkow MR; Hasserjian RP; Harris NL; Macon WR; Kurtin PJ; Rech KLG Am J Surg Pathol; 2018 Dec; 42(12):1647-1652. PubMed ID: 30222603 [TBL] [Abstract][Full Text] [Related]
13. Giant lymph node hyperplasia of the hyaline vascular type with plasmacytoid T-cells and presentation in infancy. Hunt SJ; Anderson WD Am J Clin Pathol; 1989 Mar; 91(3):344-7. PubMed ID: 2466400 [TBL] [Abstract][Full Text] [Related]
14. Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease. Quesada AE; Young KH; Medeiros LJ; Thakral B Pathology; 2018 Apr; 50(3):351-352. PubMed ID: 29486963 [No Abstract] [Full Text] [Related]
15. Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases. Saglam A; Singh K; Gollapudi S; Kumar J; Brar N; Butzmann A; Warnke R; Ohgami RS Int J Lab Hematol; 2022 Aug; 44(4):700-711. PubMed ID: 35577551 [TBL] [Abstract][Full Text] [Related]
17. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347 [TBL] [Abstract][Full Text] [Related]
19. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta. Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945 [TBL] [Abstract][Full Text] [Related]
20. A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features. Igawa T; Omote R; Sato H; Taniguchi K; Miyatani K; Yoshino T; Sato Y Pathol Res Pract; 2017 Nov; 213(11):1378-1383. PubMed ID: 28974340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]